The store will not work correctly when cookies are disabled.
1-methyl-7-(naphthalen-1-ylmethoxy)-9H-pyrido[3,4-b]indole
ID: ALA2164707
PubChem CID: 54767535
Max Phase: Preclinical
Molecular Formula: C23H18N2O
Molecular Weight: 338.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nccc2c1[nH]c1cc(OCc3cccc4ccccc34)ccc12
Standard InChI: InChI=1S/C23H18N2O/c1-15-23-21(11-12-24-15)20-10-9-18(13-22(20)25-23)26-14-17-7-4-6-16-5-2-3-8-19(16)17/h2-13,25H,14H2,1H3
Standard InChI Key: UDUMVLIVSFJGGL-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
11.5611 -24.5293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5600 -25.3566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2747 -25.7695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2730 -24.1164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9884 -24.5256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9886 -25.3520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7747 -25.6072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7743 -24.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2585 -24.9365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0758 -24.8496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4100 -24.0969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9207 -23.4303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1051 -23.5204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8452 -25.7685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5614 -25.5165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1310 -25.3555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1316 -24.5305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8462 -24.1188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8488 -23.2974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1365 -22.8804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4156 -24.1188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4215 -23.2924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7100 -22.8759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9920 -23.2847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9901 -24.1142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7022 -24.5269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 9 1 0
8 5 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
2 14 1 0
10 15 1 0
14 16 1 0
16 17 1 0
17 18 1 0
17 21 2 0
18 19 2 0
19 20 1 0
20 22 2 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 338.41 | Molecular Weight (Monoisotopic): 338.1419 | AlogP: 5.76 | #Rotatable Bonds: 3 |
Polar Surface Area: 37.91 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.53 | CX Basic pKa: 6.15 | CX LogP: 4.56 | CX LogD: 4.54 |
Aromatic Rings: 5 | Heavy Atoms: 26 | QED Weighted: 0.45 | Np Likeness Score: -0.23 |
References
1. Frédérick R, Bruyère C, Vancraeynest C, Reniers J, Meinguet C, Pochet L, Backlund A, Masereel B, Kiss R, Wouters J.. (2012) Novel trisubstituted harmine derivatives with original in vitro anticancer activity., 55 (14): [PMID:22770529] [10.1021/jm300542e] |
2. Meinguet C, Bruyère C, Frédérick R, Mathieu V, Vancraeynest C, Pochet L, Laloy J, Mortier J, Wolber G, Kiss R, Masereel B, Wouters J.. (2015) 3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties., 94 [PMID:25747498] [10.1016/j.ejmech.2015.02.044] |